UNSPSC 51171656: Docusate sodium

This classification denotes a stool softener, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier F05Q2T2JA0. European Medicines Agency schedules Docusate sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06348MIG. Docusate sodium generally arises in the molecular formula C20H37NAO7S. The term 'docusate sodium' is an International Nomenclature of Cosmetic Ingredients designation.

UNSPSC 51171656 Docusate sodium is a Commodity code that maps to pharmaceutical products distributed through state and local health and corrections systems. The recent opportunities show state and local governments buying docusate as part of broader pharmaceutical procurement frameworks — either integrated into multi-source generic drug contracts covering hundreds of products, or embedded within correctional health and drug-testing service agreements that include ancillary pharmaceutical and screening needs. The issuing bodies span state pharmacy benefit programs (Texas Health and Human Services Commission), multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance), and county corrections departments (Collin County, Texas). The work centers on establishing supply contracts with manufacturers or authorized distributors, negotiating per-unit or per-package pricing, maintaining chain-of-custody and compliance documentation, and meeting FDA cGMP and drug-supply-security standards.

Recent activity concentrates in Texas and Minnesota. The Minnesota Multistate Cooperative Purchasing Alliance RFP (S1070000015802), due March 26, 2026, established a two-year generic multi-source pharmaceutical contract requiring manufacturers to supply products through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson), with evaluation weighted 75 percent on price competitiveness and 25 percent on compliance, EDI capability, and pricing format. The Texas Health and Human Services Commission issued an RFI (HHS0017013) in April 2026 to explore direct-to-manufacturer prescription fulfillment models outside traditional pharmacy benefit managers. At the county level, Collin County Community Supervision and Corrections Department posted RFP 2026-327 on July 9, 2026 (due July 23) for offender specimen collection and drug testing services valued at $600,000 over two years with three optional one-year renewals, requiring lab certification from SAMHSA, TX DPS, or CAP and pricing on a per-test basis across multiple screening and confirmation methodologies.